NEW YORK – Cancer sequencing firm Inocras said Tuesday that it has partnered with the Broad Institute for a research project that will aim to analyze cancer whole-genome sequencing data.
Financial and other details of the deal were not disclosed.
As part of the collaboration, Inocras will sponsor several Broad research teams, including groups led by Gad Getz and Esther Rheinbay, to analyze “a substantial dataset" of cancer whole-genome sequencing data.
“This project will significantly advance our understanding of whole cancer genomes and has the potential to improve cancer precision medicine,” Inocras Cofounder Youngseok Ju said in a statement.
Formerly called Genome Insight, San Diego-based Inocras is a spinout from the Korea Advanced Institute of Science and Technology (KAIST), which is developing whole-genome sequencing assays as well as data curation pipelines for cancer and rare diseases.